National Food Chain Safety Office Directorate of Veterinary Medicinal Products

Size: px
Start display at page:

Download "National Food Chain Safety Office Directorate of Veterinary Medicinal Products"

Transcription

1 National Food Chain Safety Office Directorate of Veterinary Medicinal Products Reg. no.: 02,2/02672/0035/2014 Officer: Dr. Hajós Anna Attachment: Package Leaflet and labelling Re.: Amendment of registration of Ovopel Hungary A.U.V. product Mailing address: Dr. Horváth László, Interfish Kft Budapest, Kánai út 5. fsz. 6. Interfish Kft. Budapest Dear Dr. Hováth László, Please be informed that the Ovopel Hungary A.U.V. product registered under no. 001/2005/ÁOGYTI is now registered with the attached amended package leaflet and labelling. The administrative service fee for this regulatory procedure is HUF 30,000, which amount was paid on September 8, Dated in Budapest, on September 18, 2014 (illegible signature and stamp) Dr. Kulcsár Gábor Director In two copies. The following shall be notified: 1. Client 2. Archive

2 PACKAGE LEAFLET Veterinary medicinal product for the induction of synchronized ovulation and/or spermiation of ornamental fish and non-food producing species. 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT INTERFISH Halszaporító és Tanácsadó Kft Budapest, Kánai út 5. fsz NAME OF THE VETERINARY MEDICINAL PRODUCT 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each pellet (50-55 mg) contains: Active substance: GnRH oligopeptide analogue: 25μg Metoclopramide: 20mg Excipients and carriers: Lactose, dextrose, potato starch, calcium and magnesium compounds 4. INDICATION(S) Veterinary medicinal product for the induction of synchronized ovulation and/or spermiation of ornamental fish and non-food producing species. 5. CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance or any of the excipients. 6. ADVERSE REACTIONS Each component of the product is synthetic, and, therefore, the possibility of virus transfer from one high value ornamental fish to another or within the broodstock is excluded. If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. 7. TARGET SPECIES Ornamental fish and non-food producing species* * Small number of broodstock fish, destined for breeding purposes and non-food producing, carrying the typical characteristics of the species / variety in their appearance and production, that has been previously selected through phenotypic mass selection, has been kept and handled separately and makes up a genetically valuable small stand.

3 8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION One pellet contains the sufficient amount of active substance to induce one-time ovulation in 1 kg of healthy, mature spawner fish. To induce spermiation in male fish it is enough to use the half amount of the above. 9. ADVICE ON CORRECT ADMINISTRATION Preparing the solution and administration 1. Weigh precisely in grams the fish to be treated (for propagation). 2. Count exact number of pellets required. 3. Crush pellets in porcelain crucible. 4. Add active substances to 0.6% saline solution (1 ml 0.6% NaCl solution / 1 pellet). 5. Aspire supernatant into a plastic syringe. 6. Inject appropriate amount of solution into the fish based on the measured weight. The calculated amount of solution should be administered as an intra-peritoneal injection at the base of the abdominal fin. 7. Confirm the occurrence of ovulation based on the changed behaviour of fish (mating dance starts in the incubating pool). This may occur hours after treatment depending on the temperature. 8. Collect (strip) and in vitro fertilise sex products. 9. As an alternative: fish lay eggs on the water plants placed in the pool. 10. WITHDRAWAL PERIOD The product is not authorized for food-producing fish. 11. SPECIAL STORAGE PRECAUTIONS Keep out of the reach of children. Store in a dry place Store below 25 Do not store in refrigerator. Shelf life of the veterinary medicinal product as packaged for sale: 2 years. This veterinary medicinal product can only be used before the expiry date stated on the label. Expiry date refers to the last day of the specified month.

4 12. SPECIAL WARNING(S) Special warning for operators treating the animals: People with known hypersensitivity to the active substance should avoid contact with the veterinary medicinal product. Operators should wash their hands after use of the product. Do not eat, drink or smoke when using this product. Avoid skin contact. Interaction with other medicinal products and other forms of interaction: No information is available. Overdose (symptoms, emergency procedures, antidotes): No information is available. Incompabilities: In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY Do not contaminate natural water with OVOPEL Hungary product. Ask your veterinarian about the proper of disposal of unused veterinary medicinal products. These measures protect the environment. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED 18 September OTHER INFORMATION For veterinary use only. No marketing restrictions. Registration number: 001/2005/ÁOGYTI

5 PARTICULARS TO APPEAR ON THE OUTER PACKAGE {Box of 20 vials of 20 ml (each vial contains 100 pellets)} 1. NAME OF THE VETERINARY MEDICINAL PRODUCT 2. STATEMENT OF ACTIVE AND OTHER SUBSTANCES 1 pellet (50-55 mg) contains: Active substances: GnRH oligopeptide analogue: 25µg Metoclopramide: 20mg Adjuvants and excipients: Lactose, dextrose, potato starch, calcium and magnesium compounds 3. PHARMACEUTICAL FORM Pellet 4. PACKAGE SIZE 20x100 pellets 5. TARGET SPECIES Ornamental fish and non-food producing species* * Small number of broodstock fish, destined for breeding purposes and non-food producing, carrying the typical characteristics of the species / variety in their appearance and production, that has been previously selected through phenotypic mass selection, has been kept and handled separately and makes up a genetically valuable small stand. 6. INDICATION(S) Veterinary medicinal product for the induction of synchronized ovulation and/or spermiation of ornamental fish and non-food producing species. 7. METHOD AND ROUTE(S) OF ADMINISTRATION Read the package leaflet before use

6 8. WITHDRAWAL PERIOD The product is not authorized for food-producing fish. 9. SPECIAL WARNING(S), IF NECESSARY Read the package leaflet before use! 10. EXPIRY DATE EXP {month/year} After dilution, the product should be used immediately. 11. SPECIAL STORAGE CONDITIONS Store in a dry place. Store below 25. Do not store in refrigerator. 12. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY Do not contaminate natural water with OVOPEL Hungary product. 13. THE WORDS FOR ANIMAL TREATMENT ONLY AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE For animal treatment only. No marketing restrictions. 14. THE WORDS KEEP OUT OF THE REACH AND SIGHT OF CHILDREN Keep out of the reach and sight of children. 15. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER INTERFISH Halszaporító és Tanácsadó Kft Budapest, Kánai út 5. fsz MARKETING AUTHORISATION NUMBER(S) Registration number: 001/2005/ÁOGYTI 17. MANUFACTURER S BATCH NUMBER Lot:

7 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 20 ml vial containing 100 pellets 1. NAME OF THE VETERINARY MEDICINAL PRODUCT 2. QUANTITY OF THE ACTIVE SUBSTANCE(S) GnRH oligopeptide analogue: 25µg Metoclopramide: 20mg 3. CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES 100 pieces of mg pellets 4. ROUTE(S) OF ADMINISTRATION 5. WITHDRAWAL PERIOD The product is not authorized for food-producing fish. 6. BATCH NUMBER Lot 7. EXPIRY DATE Expiry date: After dilution, the product should be used immediately. 8. THE WORDS FOR ANIMAL TREATMENT ONLY For animal treatment only.

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT ACEGON, 50 microgram/ml, solution for injection for cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active

More information

Nevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8

Nevirapine 200 mg tablets WHOPAR part 5 09/2010, version 1.0 (Matrix Laboratories Ltd), HA396 LABELLING. Page 1 of 8 LABELLING Page 1 of 8 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING HDPE bottle carton label 1. NAME OF THE MEDICINAL PRODUCT Nevirapine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ZULVAC 8 Ovis suspension for injection for sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml of

More information

SUMMARYOF PRODUCT CHARACTERISTICS

SUMMARYOF PRODUCT CHARACTERISTICS SUMMARYOF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Excis 10 mg/ml concentrate for solution for fish treatment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Cypermethrin

More information

NEUROTONE THR 00904/0005 UKPAR

NEUROTONE THR 00904/0005 UKPAR NEUROTONE THR 00904/0005 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 10 Summary of Product Characteristics Page 11 Product Information Leaflet

More information

Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS

Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Dechra Veterinary Products Limited (A business unit of Dechra Pharmaceuticals PLC) Sansaw Business Park Hadnall, Shrewsbury Shropshire SY4 4AS Tel: 01939 211200 Fax: 01939 211201 Email: info.uk@dechra.com

More information

Public Assessment Report UKPAR. Levonorgestrel 1.5 mg tablet. (levonorgestrel). UK Licence No: PL 41947/0006. ELC Group s.r.o.

Public Assessment Report UKPAR. Levonorgestrel 1.5 mg tablet. (levonorgestrel). UK Licence No: PL 41947/0006. ELC Group s.r.o. Public Assessment Report UKPAR Levonorgestrel 1.5 mg tablet (levonorgestrel). UK Licence No: PL 41947/0006 ELC Group s.r.o. 1 LAY SUMMARY Levonorgestrel 1.5 mg tablet (Levonorgestrel, tablet, 1.5 mg) This

More information

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof; DIRECTIVE 65/65/EEC Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ L No 22 of

More information

Medicine Record Book

Medicine Record Book Medicine Record Book Medicine Administration and Purchase Record Book (and Beef/Lamb Stock Health Plan) Name:.. Address:........ Assurance Number:. CONTENTS Foreword Animal Health Plan (Beef& Lamb only)

More information

General Legal Requirements A guide for pharmacists in Northern Ireland 2010 Edition. Medicines for Veterinary Use

General Legal Requirements A guide for pharmacists in Northern Ireland 2010 Edition. Medicines for Veterinary Use General Legal Requirements A guide for pharmacists in Northern Ireland 2010 Edition 5 Medicines for Veterinary Use 5 MEDICINES FOR VETERINARY USE The Veterinary Medicines Regulations SI No. 2297 came into

More information

Reconstitution of Solutions

Reconstitution of Solutions Chapter 12 Reconstitution of Solutions Reconstitution Process of mixing and diluting solutions Some medications supplied in powder form and must be mixed with liquid before administration Parts of Solutions

More information

AQUATIC ANIMAL MEDICINE RECORD BOOK

AQUATIC ANIMAL MEDICINE RECORD BOOK AQUATIC ANIMAL MEDICINE RECORD BOOK FISH HEALTH INSPECTORATE www.efishbusiness.co.uk It is a legal requirement for you to retain these records for at least five years following the administration or other

More information

Donepezil hydrochloride 10 mg film-coated tablets PL 19156/0130

Donepezil hydrochloride 10 mg film-coated tablets PL 19156/0130 Donepezil hydrochloride 10 mg film-coated tablets PL 19156/0130 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific Discussion Page 4 Steps Taken for Assessment Page 12 Summary of Product Characteristics

More information

Perfalgan 10 mg/ml, solution for infusion

Perfalgan 10 mg/ml, solution for infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Perfalgan 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin

PACKAGE LEAFLET: INFORMATION FOR THE USER. VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution. Cyanocobalamin PACKAGE LEAFLET: INFORMATION FOR THE USER VITAMINE B12 STEROP 1mg/1ml Solution for injection / oral solution Cyanocobalamin Read all of this leaflet carefully before you start using this medicine because

More information

BVA. British Trout Association

BVA. British Trout Association CODE OF PRACTICE ON THE RESPONSIBLE USE OF ANIMAL MEDICINES ON THE FARM THIS CODE IS SUPPORTED BY THE FOLLOWING ORGANISATIONS: BVA British Trout Association LAST UPDATED: SEPTEMBER 2008 TABLE OF CONTENTS

More information

UW School of Dentistry Comprehensive Medication Policy

UW School of Dentistry Comprehensive Medication Policy UNIVERSITY OF WASHINGTON SCHOOL OF DENTISTRY Subject: UW School of Dentistry Comprehensive Medication Policy Policy Number: Effective Date: December 2014 Revision Dates: June 2015 PURPOSE This policy provides

More information

UKPAR Goodnight THR 00904/0003. Goodnight THR 00904/0003 UKPAR TABLE OF CONTENTS. Lay Summary Page 2. Scientific discussion Page 3

UKPAR Goodnight THR 00904/0003. Goodnight THR 00904/0003 UKPAR TABLE OF CONTENTS. Lay Summary Page 2. Scientific discussion Page 3 Goodnight THR 00904/0003 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 12 Steps taken after authorisation Page 13 Summary of Product Characteristics

More information

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC

More information

ANASTROZOLE 1 MG FILM-COATED TABLETS. (Anastrozole) PL 40378/0123 UKPAR TABLE OF CONTENTS

ANASTROZOLE 1 MG FILM-COATED TABLETS. (Anastrozole) PL 40378/0123 UKPAR TABLE OF CONTENTS ANASTROZOLE 1 MG FILM-COATED TABLETS (Anastrozole) PL 40378/0123 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 11 Summary of Product Characteristics

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Prednicare Tablets 5mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Active Substance(s) Prednisolone

More information

Product Literature Standard. Version 1.1

Product Literature Standard. Version 1.1 Product Literature Standard Version 1.1 1 Contents 1. Introduction... 3 2. Definitions... 4 3. Legal Requirements... 5 4. General Requirements... 7 4.1 Scope... 7 4.2 Submission of Mock-Ups... 8 4.3 Fonts

More information

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride

Package leaflet: Information for the patient. Naloxone Hydrochloride 20 micrograms / ml Solution for Injection Naloxone hydrochloride A leaflet will be included in each pack. The leaflet will consist of a Technical Information Leaflet and a Patient Information Leaflet. The two leaflets will be easily separatable. The text of the Technical

More information

Code of Practice on the responsible use of animal medicines on the farm

Code of Practice on the responsible use of animal medicines on the farm Code of Practice on the responsible use of animal medicines on the farm Updated: December 2014 Supported by the following organisations: Table of Contents Table of Contents... 2 Introduction... 3 Animal

More information

RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS

RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS RECONSTITUTING MEDICATIONS: HOW TO FLUFF UP MEDICATIONS After the completion of this module you will be able to: Define medication reconstitution. Read a medication label. Reconstitute a medication. Calculate

More information

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride This medicine is for use in men only Read all of this leaflet carefully before you start taking this medicine because

More information

CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION

CONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed

More information

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility

More information

Urostemol Men capsules THR 02855/0240

Urostemol Men capsules THR 02855/0240 Urostemol Men capsules THR 02855/0240 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 14 Steps taken after initial registration Page 15 Summary of

More information

College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands

College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY

More information

ZOVIRAX Cold Sore Cream

ZOVIRAX Cold Sore Cream Data Sheet ZOVIRAX Cold Sore Cream Aciclovir 5% w/w Presentation Topical cream Indications ZOVIRAX Cold Sore Cream is indicated for the treatment of Herpes simplex virus infections of the lips and face

More information

skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by susceptible strains of organisms.

skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by susceptible strains of organisms. Part II SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL P 5 mg tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient Marbofloxacin 5mg per tablet

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON HYPERICUM PERFORATUM L., HERBA (TRADITIONAL USE)

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON HYPERICUM PERFORATUM L., HERBA (TRADITIONAL USE) European Medicines Agency Evaluation of Medicines for Human Use London, 12 November 2009 Doc. Ref.: EMEA/HMPC/745582/2009 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride) This medicine is for use in men only Read all of this leaflet carefully before you start to take this medicine.

More information

Aciclovir 200mg Tablets Aciclovir 400mg Tablets Aciclovir 800mg Tablets PL 29831/0517 PL 29831/0518 PL 29831/0519 UKPAR

Aciclovir 200mg Tablets Aciclovir 400mg Tablets Aciclovir 800mg Tablets PL 29831/0517 PL 29831/0518 PL 29831/0519 UKPAR Aciclovir 200mg Tablets Aciclovir 400mg Tablets Aciclovir 800mg Tablets PL 29831/0517 PL 29831/0518 PL 29831/0519 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for

More information

Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium. Applicant: Dechra Limited

Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium. Applicant: Dechra Limited NATIONAL PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium Applicant: Dechra Limited Postadress/Postal

More information

STANDARDS AND GUIDELINES TITLE: CIRCULATION DATE: March June 2013 REVISED: June 2013 APPROVAL DATE: July 29, 2013

STANDARDS AND GUIDELINES TITLE: CIRCULATION DATE: March June 2013 REVISED: June 2013 APPROVAL DATE: July 29, 2013 College of Homeopaths of Ontario 163 Queen Street East, 4 th Floor, Toronto, Ontario, M5A 1S1 TEL 416-862-4780 OR 1-844-862-4780 FAX 416-874-4077 www.collegeofhomeopaths.on.ca STANDARDS AND GUIDELINES

More information

I B2.4. Design of the patient information leaflet for VariQuin

I B2.4. Design of the patient information leaflet for VariQuin (English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to

More information

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment? The Management of Pharmaceuticals in the Environment (PIE) FAQ Key questions and answers Q: How do pharmaceuticals get into the environment? A: Like many foods and supplements that are consumed by humans

More information

Arnicare Arnica 30c pillules NR 01175/0181 UKPAR

Arnicare Arnica 30c pillules NR 01175/0181 UKPAR Arnicare Arnica 30c pillules NR 01175/0181 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 11 Summary of product characteristics Page 12 Product

More information

Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014

Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014 Agricultural and Veterinary Chemicals Code (Listed Chemical Product Home Swimming Pool and Spa Products) Standard 2014 I, Kareena Arthy, Chief Executive Officer of the Australian Pesticides and Veterinary

More information

WARNINGS PRECAUTIONS

WARNINGS PRECAUTIONS CROP GUARD LABEL WARNINGS Withholding period: Allow 43 days between application and harvest of citrus Allow 42 days between application and harvest of lettuce Allow 41 days between application and harvest

More information

LEVEL 2 AWARD IN THE SAFE USE OF PESTICIDES (QCF) (0216) FOUNDATION UNIT PA1

LEVEL 2 AWARD IN THE SAFE USE OF PESTICIDES (QCF) (0216) FOUNDATION UNIT PA1 NPTC Registered Charity No. 09649 ABBEY PARK, STARETON, WARWICKSHIRE, CV8 LY Tel: 04 7685 7300 Fax: 04 7669 68 Email: information@nptc.org.uk LEVEL AWARD IN THE SAFE USE OF PESTICIDES (QCF) (06) FOUNDATION

More information

11 MEDICATION MANAGEMENT

11 MEDICATION MANAGEMENT 1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,

More information

Report of the Veal Calf Vaccination Study with Rispoval IntraNasal (Zoetis)

Report of the Veal Calf Vaccination Study with Rispoval IntraNasal (Zoetis) Report of the Veal Calf Vaccination Study with Rispoval IntraNasal (Zoetis) Date: February 18, 2014 H. A. Vahl, H. Bekman and J. van Riel Introduction: Substantial percentages of antibiotics applied in

More information

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate

PATIENT INFORMATION LEAFLET. Calcium Sandoz Syrup calcium glubionate and calcium lactobionate PATIENT INFORMATION LEAFLET Calcium Sandoz Syrup calcium glubionate and calcium lactobionate Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to

More information

Memantine hydrochloride 20 mg film-coated tablets PL 17907/0291

Memantine hydrochloride 20 mg film-coated tablets PL 17907/0291 Memantine hydrochloride 20 mg film-coated tablets PL 17907/0291 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific Discussion Page 5 Steps Taken for Assessment Page 13 Summary of Product Characteristics

More information

UTCVM PHARMACY STANDARD OPERATING PROCEDURES

UTCVM PHARMACY STANDARD OPERATING PROCEDURES UTCVM PHARMACY STANDARD OPERATING PROCEDURES Updated: 4/5/2004 I. General Procedures A. Hours: The Pharmacy will be open Monday through Friday, 8:00AM to 6:00PM; Saturday 8:00AM to 1:00PM. The Pharmacy

More information

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember.

If you forget to use Catacrom Eye Drops If you forget to use this medicine, use it as soon as you remember. Package leaflet: Information for the user Catacrom 2 % w/v Eye Drops, Solution Sodium cromoglicate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Guidance on the content of a pharmacy manual to support clinical trial protocols

Guidance on the content of a pharmacy manual to support clinical trial protocols Guidance on the content of a pharmacy manual to support clinical trial protocols This guidance has been produced to help investigators with the content of pharmacy manuals for clinical trials. We gratefully

More information

Felimazole 5 mg Coated Tablet

Felimazole 5 mg Coated Tablet .. CARTON TEXT - FRONT PANEL PRESCRIPTION ANIMAL REMEDY READ SAFETY DIRECTIONS BEFORE OPENING OR USING KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY RLP Approved Felimazole 5 mg Coated Tablet

More information

IMPURITIES IN NEW DRUG PRODUCTS

IMPURITIES IN NEW DRUG PRODUCTS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG PRODUCTS Q3B(R2) Current

More information

Decree N 152 (24 January 2013) Administrative Measure on Inspection, Quarantine and Supervision of Imports and Exports of Dairy products

Decree N 152 (24 January 2013) Administrative Measure on Inspection, Quarantine and Supervision of Imports and Exports of Dairy products Decree N 152 (24 January 2013) Administrative Measure on Inspection, Quarantine and Supervision of Imports and Exports of Dairy products Chapter 1 General Principle Article 1 In order to enhance inspection,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dalacin C 150 mg Capsules. clindamycin hydrochloride. Dalacin C 150mg Capsules clindamycin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER PFIZER Dalacin C 150 mg Capsules clindamycin hydrochloride Dalacin C 150mg Capsules clindamycin hydrochloride PFIZER Read all of this leaflet carefully before

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE AND THE COMPANY Material Manufacturer Distributor Losartan Potassium and Hydrochlorothiazide Tablets 100 mg/12.5 mg Lupin Limited Goa 403 722

More information

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005

CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 CAC/RCP 61-2005 Page 1 of 15 CODE OF PRACTICE TO MINIMIZE AND CONTAIN ANTIMICROBIAL RESISTANCE CAC/RCP 61-2005 INTRODUCTION... 2 AIMS AND OBJECTIVES... 2 RESPONSIBILITIES OF THE REGULATORY AUTHORITIES...

More information

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL PRODUCTS DOSSIER DISCUSSION IN THE HMPWG 2003-2005 RELEASE FOR CONSULTATION December 2005 DEADLINE

More information

Instructions for Use

Instructions for Use 1 Instructions for Use HUMULIN R U-500 KwikPen insulin human injection U-500 (500 units/ml, 3 ml pen) Important: Know your dose of HUMULIN R U-500 insulin. The Pen delivers your dose in insulin units.

More information

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT VIRBAKOR 20 mg film-coated tablet for dogs Date: 03/11/2014 French agency for food, environnemental

More information

Children & Young People s Directorate. School Nursing Procedure For Administration of Immunisations

Children & Young People s Directorate. School Nursing Procedure For Administration of Immunisations Children & Young People s Directorate School Nursing Procedure For Administration of Immunisations Author Mrs Gladys Bleakley & Mrs Barbara Ervine Directorate responsible for Children & Young Peoples this

More information

Adjuvants and Excipients

Adjuvants and Excipients Adjuvants and Excipients The Food Safety and Inspection Service (FSIS) transferred the official responsibility to evaluate adjuvants and excipients used in Veterinary Biologics back to the Animal and Plant

More information

Public Assessment Report Scientific discussion. Amitriptylin Abcur (amitriptyline hydrochloride) Asp no : 2013-0678 2013-0679 2013-0680

Public Assessment Report Scientific discussion. Amitriptylin Abcur (amitriptyline hydrochloride) Asp no : 2013-0678 2013-0679 2013-0680 Public Assessment Report Scientific discussion Amitriptylin Abcur (amitriptyline hydrochloride) Asp no : 2013-0678 2013-0679 2013-0680 This module reflects the scientific discussion for the approval of

More information

HYDROCORTISONE 10 MG TABLETS

HYDROCORTISONE 10 MG TABLETS HYDROCORTISONE 10 MG TABLETS (Hydrocortisone) PL 20072/0238 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 12 Steps taken after authorisation summary

More information

Public Assessment Report

Public Assessment Report Public Assessment Report Decentralised Procedure Zoledronic Acid 4mg/5ml Concentrate for Solution for Infusion Procedure No: UK Licence No: PL 24598/0029 Noridem Enterprises Limited LAY SUMMARY On 25 January

More information

Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006

Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006 Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 9 Summary of product characteristics Page 10 Patient

More information

General Principles for the Safety Assessment of Excipients

General Principles for the Safety Assessment of Excipients General Principles for the Safety Assessment of Excipients General Characteristics of the Pharmaceutical Excipients Classification of excipients The Safety Assessment of Pharmaceutical Excipients : how

More information

drinking water medication short guide

drinking water medication short guide drinking water medication short guide Dr. Klaas van Aken DVM Optimal use of antibiotics through correct administration 2 This brochure presents a step-by-step approach to responsibly and successfully administering

More information

CODE OF PRACTICE FOR MICROCHIP DISTRIBUTORS AND MANUFACTURERS

CODE OF PRACTICE FOR MICROCHIP DISTRIBUTORS AND MANUFACTURERS CODE OF PRACTICE FOR MICROCHIP DISTRIBUTORS AND MANUFACTURERS OBJECTIVE The Code is aimed at producing minimum requirements and standards that should be put in place and adhered to by all microchip distributors,

More information

Guide to The Notification System for Exempt Medicinal Products

Guide to The Notification System for Exempt Medicinal Products Guide to The Notification System for Exempt Medicinal Products AUT-G0090-1 10 JULY 2014 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS Below is a template that can be used to produce a local patient group direction (PGD) for the administration of

More information

BRIEFING 7 LABELING DEFINITION

BRIEFING 7 LABELING DEFINITION Page 1 of 10 BRIEFING 7 Labeling. This general chapter provides definitions and standards for labeling of official articles. Note that, as with compendial quality standards, labeling requirements also

More information

HUMULIN 70/30 KwikPen

HUMULIN 70/30 KwikPen 1 Instructions for Use HUMULIN 70/30 KwikPen (70% human insulin isophane suspension 30% human insulin injection [rdna origin]) Read the Instructions for Use before you start taking HUMULIN 70/30 and each

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

STANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES

STANDARD OPERATING PROCEDURE #401 CONTROLLED SUBSTANCES STANDARD OERATING ROCEDURE #401 CONTROLLED SUBSTANCES 1. UROSE This Standard Operating rocedure (SO) describes procedures for acquiring, storing, using and discarding controlled substances. 2. RESONSIBILITY

More information

DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Parque Empresarial Las Mercedes Edificio 8 C/ Campezo, 1 E - 28022 Madrid Spain (Reference Member State) DECENTRALISED PROCEDURE PUBLICLY

More information

Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material)

Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material) Radiation Sciences Nuclear Medicine Technology Program Hot Lab Log Book (Material) Table of Content Receiving a Radioactive Package Constancy Test Daily Survey Weekly Wipes Accuracy Test Linearity Geometric

More information

Omeprazole 20 mg gastro-resistant tablets PL 14017/0277

Omeprazole 20 mg gastro-resistant tablets PL 14017/0277 Omeprazole 20 mg gastro-resistant tablets PL 14017/0277 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific Discussion Page 4 Steps Taken for Assessment Page 11 Steps Taken After Initial Authorisation

More information

PART I: PREPARATION OF SOLUTIONS AND STANDARDIZATION OF A BASE

PART I: PREPARATION OF SOLUTIONS AND STANDARDIZATION OF A BASE TITRATION: STANDARDIZATION OF A BASE AND ANALYSIS OF STOMACH ANTACID TABLETS 2009, 1996, 1973 by David A. Katz. All rights reserved. Reproduction permitted for education use provided original copyright

More information

Health Professions Act BYLAWS SCHEDULE F. PART 2 Hospital Pharmacy Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 2 Hospital Pharmacy Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 2 Hospital Pharmacy Standards of Practice Table of Contents 1. Application 2. Definitions 3. Drug Distribution 4. Drug Label 5. Returned Drugs 6. Drug Transfer

More information

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you.

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you. leaflet: Information for the user Macrogol 4000 10 g powder for oral solution in sachet Macrogol 4000

More information

GUIDELINES ON COMPOUNDING OF MEDICINES. March 2015. PharmBA1502 01

GUIDELINES ON COMPOUNDING OF MEDICINES. March 2015. PharmBA1502 01 GUIDELINES ON COMPOUNDING OF MEDICINES March 2015 PharmBA1502 01 Contents Who needs to use these guidelines?............................................. 3 Introduction..........................................................

More information

RULE. The Administration of Medication in Louisiana Public Schools

RULE. The Administration of Medication in Louisiana Public Schools RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments

More information

Public Assessment Report Scientific discussion. Prednisolon Pilum (prednisolone) Asp no: 2013-0498

Public Assessment Report Scientific discussion. Prednisolon Pilum (prednisolone) Asp no: 2013-0498 Public Assessment Report Scientific discussion Prednisolon Pilum (prednisolone) Asp no: 2013-0498 This module reflects the scientific discussion for the approval of Prednisolon Pilum. The procedure was

More information

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution

Package leaflet: Information for the patient. Laxido Orange, powder for oral solution Package leaflet: Information for the patient Laxido Orange, powder for oral solution Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Food Safety Guidance for Farmers Markets

Food Safety Guidance for Farmers Markets Food Safety Guidance for Farmers Markets Anyone selling food or drink from a market stall must comply with food hygiene legislation. Foods which are categorised as high risk include cooked meats, fish

More information

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection

Medication Guide. SYMLIN (SĬM-lĭn) (pramlintide acetate) injection Page 1 Medication Guide SYMLIN (SĬM-lĭn) (pramlintide acetate) injection Read the Medication Guide and the Patient Instructions for Use that come with your SYMLIN product before you start using it and

More information

Promoting safer use of injectable medicines

Promoting safer use of injectable medicines Promoting safer use of injectable medicines A template standard operating procedure for: prescribing, preparing and administering injectable medicines in clinical areas Introduction The use of injectable

More information

Lacidipine 2 mg Film-Coated Tablets PL 08553/0502. Lacidipine 4 mg Film-Coated Tablets PL 08553/0503. UK Public Assessment Report

Lacidipine 2 mg Film-Coated Tablets PL 08553/0502. Lacidipine 4 mg Film-Coated Tablets PL 08553/0503. UK Public Assessment Report Lacidipine 2 mg Film-Coated Tablets PL 08553/0502 Lacidipine 4 mg Film-Coated Tablets PL 08553/0503 UK Public Assessment Report TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 4 Steps taken

More information

College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands

College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands MEB agency / Veterinary Medicinal Products Unit The Netherlands C B G M E B College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Buprenovet 0.3 mg/ml Solution for Injection for Dogs and Cats (AT, DE)

SUMMARY OF PRODUCT CHARACTERISTICS. Buprenovet 0.3 mg/ml Solution for Injection for Dogs and Cats (AT, DE) SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats (UK, BE, FR, IE, LU, NL, ES) Buprenovet 0.3 mg/ml Solution for

More information

Public Assessment Report Scientific discussion. Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no: 2011-0921

Public Assessment Report Scientific discussion. Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no: 2011-0921 Public Assessment Report Scientific discussion Prednisolon Alternova (previous Prednisolon E Consult) (prednisolone) Asp no: 2011-0921 This module reflects the scientific discussion for the approval of

More information

Chapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved.

Chapter 15. Reconstitution and Dosages Measured in Units. Copyright 2012, 2007 Mosby, Inc., an affiliate of Elsevier Inc. All rights reserved. Chapter 15 Reconstitution and Dosages Measured in Units 1 Objectives Calculating drug dosage problems that first require reconstitution of a powdered drug into a liquid form Using a proportion to solve

More information

Guidelines and Procedure for the Safe Administration and Management of Medicines

Guidelines and Procedure for the Safe Administration and Management of Medicines Appendix 7 Guidelines and Procedure for the Safe Administration and Management of Medicines 1. INTRODUCTION 1.1 This procedure must be read in conjunction with the Policy for the Administration of Medication

More information

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)

CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist

More information

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate

Package leaflet: Information for the patient. Bricanyl Tablets 5 mg terbutaline sulfate Package leaflet: Information for the patient Bricanyl Tablets 5 mg terbutaline sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

ADVICE FOR OWNERS OF PET PIGS AND MICRO PIGS

ADVICE FOR OWNERS OF PET PIGS AND MICRO PIGS ADVICE FOR OWNERS OF PET PIGS AND MICRO PIGS Guidance on the legal obligations of pig keepers ADVICE AND GUIDANCE This leaflet is designed for people who keep, or are considering keeping, pigs or micro

More information

Medication Administration Guidelines for Child Care Programs

Medication Administration Guidelines for Child Care Programs Medication Administration Guidelines for Child Care Programs A. Medication Administration Policy The child care program will administer medication to children for whom a plan has been made and approved

More information

Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care

Pharmaceutical Waste Management Program St. Joseph Mercy Oakland. Pharmacy/Patient Care Pharmaceutical Waste Management Program St. Joseph Mercy Oakland Pharmacy/Patient Care Objectives Understand the background and regulatory requirements Identify pharmaceutical waste and how to dispose

More information

Advice for owners of Pet and Micro Pigs

Advice for owners of Pet and Micro Pigs Advice for owners of Pet and Micro Pigs Introduction This information is designed for people who keep, or are considering keeping pigs or micro-pigs as pets or as a hobby. While owners may regard their

More information